PHLARE
Live / Applied — First extension granted (statement of use) (as of 23 Feb 2026)
What this means for you
Not registered yet, but its 20 Jun 2024 filing date beats anything filed after it. If it registers, the owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 98611236
- Mark type
- Stylized text
- Filed
- 20 Jun 2024
- Published for opposition
- 01 Jul 2025
- Attorney of record
- Scott M. Sisun, Esq.
Goods and services
- Class 005 — Pharmaceuticals: pharmaceutical preparations for the prevention and treatment of cancer; chemical and biochemical preparations and substances for medical purposes for the prevention and treatment of cancer; biological preparations for the prevention and treatment of cancer
- Class 042 — Scientific and technological services: pharmaceutical drug development services; scientific research; pharmaceutical research services; research and development in the pharmaceutical and biotechnology fields
Owner
- Clasp Therapeutics, Inc., Rockville, MD, US
- Clasp Therapeutics, Inc., Rockville, MD, US
Prosecution history
- 24 Feb 2026 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 23 Feb 2026 — SOU EXTENSION 1 GRANTED
- 23 Feb 2026 — SOU EXTENSION 1 FILED
- 23 Feb 2026 — SOU TEAS EXTENSION RECEIVED
- 26 Aug 2025 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
- 01 Jul 2025 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 01 Jul 2025 — PUBLISHED FOR OPPOSITION
- 25 Jun 2025 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 29 May 2025 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 29 Apr 2025 — TEAS/EMAIL CORRESPONDENCE ENTERED
- 29 Apr 2025 — CORRESPONDENCE RECEIVED IN LAW OFFICE
- 29 Apr 2025 — APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
- 29 Apr 2025 — ASSIGNED TO LIE
- 14 Apr 2025 — TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
- 12 Mar 2025 — TEAS CHANGE OF CORRESPONDENCE RECEIVED